Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Anne-Genevieve Marcelin
Risk Factors for Selection of the L74I Reverse Transcriptase Mutation in Human Immunodeficiency Virus Type 1-Infected Patients
Antimicrobial Agents and Chemotherapy
Infectious Diseases
Pharmacology
Related publications
Substrate Inhibition of the Human Immunodeficiency Virus Type 1 Reverse Transcriptase.
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
RNA Pseudoknots That Inhibit Human Immunodeficiency Virus Type 1 Reverse Transcriptase.
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Frequency of Mutations Conferring Resistance to Nucleoside Reverse Transcriptase Inhibitors in Human Immunodeficiency Virus Type 1-Infected Patients in Korea
Journal of Clinical Microbiology
Microbiology
Incorporation of Human Immunodeficiency Virus Type 1 Reverse Transcriptase Into Virus-Like Particles
Journal of Virology
Insect Science
Immunology
Microbiology
Virology
The Structure of Unliganded Reverse Transcriptase From the Human Immunodeficiency Virus Type 1.
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Human Immunodeficiency Virus-1 Reverse Transcriptase Heterodimer Stability
Protein Science
Biochemistry
Medicine
Molecular Biology
Structural Basis of Asymmetry in the Human Immunodeficiency Virus Type 1 Reverse Transcriptase Heterodimer
The M184V Mutation in the Reverse Transcriptase of Human Immunodeficiency Virus Type 1 Impairs Rescue of Chain-Terminated DNA Synthesis
Journal of Virology
Insect Science
Immunology
Microbiology
Virology
Modulation of Human Immunodeficiency Virus Type 1 Synergistic Inhibition by Reverse Transcriptase Mutations
